| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10911391 | Lung Cancer | 2011 | 5 Pages |
Abstract
Gemcitabine-platinum regimens are able to control symptoms and disease progression with a modest toxicity profile. The present results from a small series of patients should be confirmed by a prospective trial in a larger cohort of patients.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Giulia Pasello, Samuele Nicotra, Giuseppe Marulli, Federico Rea, Laura Bonanno, Paolo Carli, Cristina Magro, Antonio Jirillo, Adolfo Favaretto,